Superdisintegrant designed for rapid disintegration and dissolution of solid dosage forms such as tablets and hard capsules. Benefits: It is effective at low concentration level It offers long-term dissolution stability It complies with USP-NF, Ph. Eur., BP and IP specifications

Superdisintegrant designed for rapid disintegration and dissolution of solid dosage forms such as tablets and hard capsules. From corn starch. Benefits: Effective at low concentration level Offers long-term dissolution stability Complies with USP-N, Ph. Eur., BP and IP specifications

Superdisintegrant designed for rapid disintegration and dissolution of solid dosage forms such as tablets and hard capsules. From potatoe starch. Benefits: Effective at low concentration level Offers long-term dissolution stability Complies with USP-N, Ph. Eur., BP and IP specifications

.

The FC-MX FLO-COATER® multi-purpose pilot/production Fluid Bed System is uniquely engineered to meet the specific requirements for every installation. Every FC-MX FLO-COATER® is backed by FREUND’s comprehensive range of services, including product and process development, process scale-up and transfer, calibration and maintenance programs, and proactive project management. Simple to use, economical and designed for maximum processing effectiveness, the FC-MX FLO-COATER® series is the ideal solution for your current and future fluid bed processing requirements.

We are offering high quality of Fenbendazole. We are known for manufacturing, exporting, distributing, trading and supplying Fenbendazole Gujarat, India. Further, this is safely packaged by our professionals in diverse packaging options that maintain its purity and effectiveness .Shreeji Pharma International is leading Manufacturer, Exporter, Distributor, and Supplier of Fenbendazole in Gujarat. India. Shreeji Pharma International manufacturing & supplying all products under GMP site with all types of regulatory supports. Shreeji Pharma International is the largest manufacturer, Exporter and supplier of Fenbendazole Nowadays Shreeji Pharma International is one of the leading manufacturer and exporter, who is manufacturing Fenbendazole as well as Intermediates of Fenbendazole. Shreeji Pharma International is exporter, supplier, distributor and manufacturers of the Active Pharmaceuticals Ingredients in many countries for many years. Shreeji Pharma International currently export Fenbendazole to countries like Gulf Countries, South East Asia countries, African Countries, CIS Countries, LATAM countries, Central American Countries and in European countries Fenbendazole API Powder is the active pharmaceutical ingredient (API) in a range of anthelmintic medications commonly used to treat parasitic infections in both humans and animals. It is primarily utilized as a broad-spectrum dewormer that targets a variety of nematodes (roundworms), cestodes (tapeworms), and trematodes (flukes). Fenbendazole is often used in veterinary medicine to treat parasitic infections in pets, livestock, and other animals. Here’s a detailed description of Fenbendazole API Powder: Active Ingredient : Fenbendazole (chemical name: 5-phenylthio-1H-benzimidazole-2-yl-carbamate) is a benzimidazole-based anthelmintic. Fenbendazole is the active compound in the API powder, and it is typically used in the final formulation as a tablet, powder, suspension, or granules for oral administration.

Example of recent achievement: a 500 L stainless steel pilot fermenter, GMP, for the production of cells for pharmaceutical use.

Ferric Ammonium Citrate is an iron supplement used for treating iron deficiency anemia and other iron-related deficiencies. The formulation contains a stable iron (III) complex, with ammonium citrate as the stabilizing agent. This combination allows for slow and controlled release of iron, ensuring better absorption and lower gastrointestinal irritation compared to traditional iron salts. The biocompatible nature of Ferric Ammonium Citrate also makes it suitable for patients with malabsorption issues or those who cannot tolerate other iron supplements. Due to its controlled release, Ferric Ammonium Citrate offers enhanced safety, making it suitable for long-term treatment and use in vulnerable populations. The product has a well-established safety profile, making it a reliable choice for clinicians and patients. Key Features: • Slow and controlled release of iron for consistent supplementation • Non-irritating formulation for better gastrointestinal tolerance • Suitable for patients with iron deficiency anemia and malabsorption issues • Improved patient adherence with minimal side effects • Ideal for long-term iron therapy Applications: • Iron Deficiency Anemia • Chronic Anemia Management • Malabsorption Syndromes • Long-term Iron Supplementation

Ferric Carboxymaltose (FCM) is a scientifically advanced intravenous iron replacement therapy developed for effective management of iron deficiency anemia. Unlike conventional iron salts, it is a carbohydrate-based iron (III) complex, offering superior stability, safety, and patient tolerability. The formulation is colourless, odourless, and non-hygroscopic, eliminating the metallic taste and moisture sensitivity commonly associated with traditional iron preparations. As a leading API manufacturer, WBCIL follows strict cGMP and ISO quality systems, backed by manufacturing expertise since 1962, ensuring consistent potency, purity, and safety. Key Therapeutic Advantages: • High-dose iron delivery with rapid correction of iron deficiency • Controlled iron release minimizing adverse reactions • Fewer infusions compared to conventional IV iron therapies • Improved patient compliance and clinical outcomes WBCIL Product Highlights: • Two patents held by WBCIL on Ferric Carboxymaltose • Two eminent scientific journals have published studies on WBCIL’s FCM • Minimal hypersensitivity reactions reported • Sameness study completed with the innovator product • Compliant with Indian Pharmacopoeia (IP) • Supported by COPP and Written Confirmation (WC) Applications in Medical Fields: • Iron Deficiency Anemia Treatment • Chronic Kidney Disease • Rapid Iron Replenishment • Postpartum Anemia • Chronic Heart Failure • Inflammatory Bowel Disease

Ferric Citrate is a ferric iron–citric acid complex developed for dual therapeutic benefits. It acts as an iron replacement while also serving as an effective phosphate binder. Ferric Citrate releases iron in a controlled manner and binds dietary phosphate in the gut, making it particularly useful for patients with chronic kidney disease. Its dual functionality reduces pill burden and supports better treatment adherence. Key Features: • Dual action: iron replacement and phosphate binding • Controlled iron release • Improved patient compliance Applications: • Iron Deficiency Anemia • Chronic Kidney Disease • Hyperphosphatemia Management